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Background: Plants are recognized as an efficient and inexpensive system to produce valuable recombinant
proteins. Two different strategies have been commonly used for the expression of recombinant proteins in plants:
transient expression mediated by Agrobacterium; or stable transformation of the plant genome. However, the use of
plants as bioreactors still faces two main limitations: low accumulation levels of some recombinant proteins and
lack of efficient purification methods. Elastin-like polypeptide (ELP), hydrophobin I (HFBI) and Zera® are three fusion
partners found to increase the accumulation levels of recombinant proteins and induce the formation of protein
bodies (PBs) in leaves when targeted to the endoplasmic reticulum (ER) in transient expression assays. In this study
the effects of ELP and HFBI fusion tags on recombinant protein accumulation levels and PB formation was
examined in stable transgenic Nicotiana tabacum.
Results: The accumulation of recombinant protein and PB formation was evaluated in two cultivars of Nicotiana
tabacum transformed with green fluorescent protein (GFP) fused to ELP or HFBI, both targeted and retrieved to the
ER. The ELP and HFBI tags increased the accumulation of the recombinant protein and induced the formation of
PBs in leaves of stable transgenic plants from both cultivars. Furthermore, these tags induced the formation of PBs
in a concentration-dependent manner, where a specific level of recombinant protein accumulation was required for
PBs to appear. Moreover, agro-infiltration of plants accumulating low levels of recombinant protein with p19, a
suppressor of post-transcriptional gene silencing (PTGS), increased accumulation levels in four independent
transgenic lines, suggesting that PTGS might have caused the low accumulation levels in these plants.
Conclusion: The use of ELP and HFBI tags as fusion partners in stable transgenic plants of tobacco is feasible and
promising. In a constitutive environment, these tags increase the accumulation levels of the recombinant protein
and induce the formation of PBs regardless of the cultivar used. However, a specific level of recombinant protein
accumulation needs to be reached for PBs to form.
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The fast-growing demand of recombinant proteins and
the limitations of traditional production systems (bac-
teria, fungi and mammalian cell cultures) have outlined
the need for alternative strategies of high-level recom-
binant protein production [1-3]. Production of recom-
binant proteins in plants has been used for proof of* Correspondence: rima.menassa@agr.gc.ca
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reproduction in any medium, provided the orconcept production of a wide range of proteins including
industrial enzymes and biopharmaceuticals [4,5]. The
first plant-made pharmaceutical for human use was re-
cently approved by the US Food and Drug Administra-
tion [6].
A wide range of host plants have been developed and
tested for molecular farming, however tobacco still re-
mains one of the favorite hosts for the commercial produc-
tion of recombinant proteins [7,8]. Genetic manipulation
of tobacco is well established, and its high biomass yield
(more than 100,000 kg of tissue per hectare) facilitatesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Moreover, different Nicotiana varieties have been charac-
terized according to their agronomic properties and ability
to accumulate recombinant proteins, therefore facilitating
the search for the most effective tobacco host for recom-
binant protein production [9]. Since the tobacco expres-
sion platform is based on leaves which are harvested
before flowering, the risk of pollen or seed dispersal of the
transgene is reduced [10]. Furthermore, tobacco is a non-
food, non-feed crop, which lowers the risk of plant-made
recombinant proteins entering the human and animal food
chain [3,11]. Although tobacco is inherently biosafe, the
commercial viability of molecular farming with this plant
species has been limited by two main factors: low accumu-
lation levels of some recombinant proteins and lack of effi-
cient and scalable protein purification methods [8,9].
A wide variety of strategies have been tested in plant-
based systems to increase the stability and yield of
recombinant proteins. In recent years, fusion protein
technology has been used to enhance recombinant pro-
tein accumulation in heterologous systems. Among
these, oil body-targeted oleosin fusion proteins and ER-
targeted fusion proteins with elastin-like Polypeptide
(ELP), hydrophobin I (HFBI) and Zera® have been of
particular interest as they improve accumulation and
stability of recombinant proteins in plants, and assist in
the subsequent purification process of the recombinant
proteins [12-18].
ELPs are synthetic polypeptides made up of a repeat-
ing five amino acid motif (Val-Pro-Gly-Xaa-Gly) similar
to repetitive pentapeptides of the mammalian protein
elastin. The guest amino acid (Xaa) can be any amino
acid except proline. Upon an increase in temperature,
soluble ELPs undergo a reversible transition into β spiral
structures resulting in hydrophobic, insoluble aggregates.
The transition temperature (Tt) at which phase transi-
tion occurs depends on the number of pentapeptide re-
peats and on the guest amino acid [19,20]. This property
of ELPs can be transferred to their fused protein partner
and facilitates the purification of target proteins with a
rapid, non-chromatographic purification method known
as inverse transition cycling (ITC) [21].
Protein fusions with synthetic ELP tags retrieved to
the ER using a C-terminal peptide (H/KDEL) have been
successfully produced in plants and purified with ITC.
Some examples include fusions with cytokines, anti-
bodies and spider silk, all produced in transgenic to-
bacco plants, reviewed by Floss et al. [22].
Hydrophobins are a group of small, surface-active pro-
teins originally identified in filamentous fungi [23].
These proteins play an important role in fungal growth
and development involving adaptation of fungi to their
environment [24,25]. One remarkable feature of these
proteins is that one part of their surface is made ofhydrophobic aliphatic side chains that form an exposed
hydrophobic patch on one side of the protein [25]. Alter-
natively to a core stabilized by hydrophobic interactions,
hydrophobins possess a characteristic pattern of eight
conserved cysteine (Cys) residues, which form four intra-
molecular disulfide bridges that convey a high degree of
protein stability [24]. Due to their structural properties,
hydrophobins can self-assemble into an amphipathic pro-
tein membrane at hydrophilic-hydrophobic interfaces
[26,27]. Therefore, purification of HFBI can be facilitated
by using a two-step surfactant-based aqueous two-phase
system (ATPS) [28]. Importantly, when fused to other pro-
teins, hydrophobins can alter the hydrophobicity of the fu-
sion partner allowing for simple, rapid, efficient, scalable,
and inexpensive purification using ATPS [29].
Fusions with hydrophobin I (HFBI) from Trichoderma
reesei [23] have been successfully used to overexpress
and purify recombinant proteins from Trichoderma sp.,
insect cells and plant tissues [29-31]. Transient expres-
sion of endoplasmic reticulum (ER) targeted green fluor-
escent protein (GFP) fused to ELP and HFBI tags has
shown that ELP and HFBI not only increase accumula-
tion levels of the fused recombinant protein, but also in-
duce the formation of ER-derived protein bodies (PBs)
in leaves of Nicotiana benthamiana [14,30]. These PBs
are comparable to the ones observed in leaves of stably
or transiently transformed tobacco plants with Zera® or
zeolin fusion proteins [15,32-34]. It is thought that these
induced PBs enhance the accumulation levels of fusion
proteins by stably storing large amounts of recombinant
proteins without affecting the normal growth and devel-
opment of the host plants [8,15,30].
Analysis of ELP and HFBI fusions for protein recovery
and biological activity showed that the proteins of inter-
est maintain their functionality which further confirmed
the potential of the fusion protein approach [13,22,30].
However, the majority of successful examples in which
massive amounts of fused proteins were produced and
PBs were induced have been carried out in transient ex-
pression systems using Agrobacterium infiltration. In this
study, we evaluated the effect of ER-targeted GFP-ELP
and GFP-HFBI fusions in stable transgenic tobacco
plants. Our results demonstrate that both of these tags
increase accumulation levels of GFP and induce the for-
mation of PBs in a concentration-dependent manner
where a threshold level of accumulation is necessary for
PB formation.
Results
Generation of transgenic tobacco (N. tabacum) plants
To evaluate the effect of ELP and HFBI tags on accumu-
lation levels of GFP and their potential ability to induce
PB formation in transgenic tobacco, previously published
plant expression vectors (GFP, GFP-ELP and GFP-HFBI)
Figure 1 Schematic representation of constructs used to
generate transgenic tobacco plants. TE, Translational enhancer
from the tobacco tCUP promoter. PR1b, Secretory signal peptide
from the pathogenesis related protein 1. eGFP, Enhanced green
fluorescent protein. L, Linker (GGGS)3. HFBI, Hydrophobin I tag. ELP,
Elastin-like polypeptide tag. StrepII, Fusion tag for detection and
purification of recombinant protein. KDEL, ER retention peptide. Size
of each element of the DNA constructs is not proportional to the
actual sequence length [14,30].
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(Table 1). These constructs were designed to express
ER-targeted GFP, GFP-HFBI and GFP-ELP fusion pro-
teins in tobacco plants under the control of the double
enhanced cauliflower mosaic virus (CaMV) 35S pro-
moter [35], a tCUP translational enhancer [36], and the
nopaline synthase (nos) terminator [37] in the plant
expression vector pCaMterX [38] (Figure 1), and were
reported to increase expression levels of GFP and also to
induce formation of PBs when transiently expressed in
N. benthamiana leaves [8,30]. As well, two Nicotiana
tabacum cultivars, I64 and 81V9, were shown to be
among the most effective candidates for production of
recombinant proteins in tobacco with respect to several
properties including growth rate, leaf biomass yield, high
soluble protein levels and low alkaloid content [9]. Al-
though cv. I64 produces higher biomass than cv. 81V9,
it has higher alkaloid levels, and elevated alkaloid levels
may limit the therapeutic applications of whole plant tis-
sue. Therefore, depending on the end use of the protein
of interest (therapeutic vs. industrial; purified vs. whole
tissue administration), one cultivar may be more desir-
able than the other. Therefore, we generated twenty four
independent transgenic I64 lines with each of the three
constructs to conduct a construct comparison, and twenty
four transgenic 81V9 lines expressing the GFP-HFBI con-
struct were produced to allow for a comparison of the two
cultivars. All transgenic plants displayed a normal pheno-
type when compared with untransformed plants.
Quantification of recombinant proteins in transgenic
tobacco lines
GFP accumulation levels were quantified for tobacco
plants expressing GFP, GFP-ELP and GFP-HFBI. The
observed distribution of recombinant protein accumula-
tion in different stable transgenic lines reflected the typ-
ical trend of a transgenic population where variability in
accumulation levels across the primary transgenic lines
is expected (Figure 2). This variability can be explained
by positional effect of the transgene insertion within the
genome, transgene copy number and/or silencing mecha-






Recombinant protein Number of
transgenic lines
I64 GFP GFP, targeted to the ER 24
I64 GFP-ELP GFP with ELP tag,
targeted to the ER
24
I64 GFP-HFBI GFP with HFBI tag,
targeted to the ER
24
81V9 GFP-HFBI GFP with HFBI tag,
targeted to the ER
24In general, most unfused GFP-expressing plants had
lower accumulation of GFP than plants expressing GFP-
ELP and GFP-HFBI; accumulation levels appeared to be
higher in GFP-HFBI lines than in GFP-ELP lines, and no
significant differences were detected between 81V9 and
I64 populations expressing GFP-HFBI (Figure 2).
To validate the observation that both fusion tags ap-
pear to increase accumulation levels of the recombinant
protein in transgenic plants, statistical analyses of the
primary transformants were performed. A normality test
was first applied to the recombinant protein quantifica-
tion data gathered from all of the independent trans-
formants generated per construct. As expected for small
populations of first-generation transgenic plants, the as-
sumption of normality was not met [41]. Therefore, a
Kruskal-Wallis test (equivalent to parametric analysis of
variance, ANOVA) was performed to evaluate if there
were statistical differences between the four groups of
transgenic lines. The test results demonstrated that there
were significant differences between the median values
of the four transgenic groups (P < 0.001). Consequently,
a Wilcoxon-Mann–Whitney test was applied to compare
the four transgenic groups (Figure 3). Results demon-
strated that the ELP and HFBI tags have a significant
positive effect on the accumulation levels of GFP in
stable transgenic plants when compared to GFP with no
fusion tag, that HFBI improves GFP accumulation levels
significantly more than ELP, and that there is no signifi-
cant difference between cultivars I64 and 81V9 express-
ing GFP-HFBI (Figure 3).
Protein body formation in transgenic N. tabacum plants
To evaluate the subcellular localization of ER-targeted
GFP, GFP-HFBI and GFP-ELP, confocal laser scanning
microscopy was performed on several leaves of multiple
plants including a young, a medium-sized and an old
leaf (Figure 2, Additional file 1: Tables S1, S2, S3 and
S4). As untransformed plants showed no evidence of the
green fluorescence signal (data not shown), the observed
fluorescence in all transgenic lines was attributed to
Figure 2 Distribution of GFP, GFP-ELP and GFP-HFBI accumulation in independent transgenic tobacco lines. Dark green bars, plants with
PBs. Gray bars, transgenic lines which did not display PB formation or which were not analyzed by confocal microscopy. Arrows identify
transgenic plants analyzed by confocal microscopy. The X-axis represents independent transgenic T0 lines, and the Y-axis represents the amount
of GFP produced by each transgenic T0 line as determined by dot-blot analysis of triplicate loading of each sample.
Gutiérrez et al. BMC Biotechnology 2013, 13:40 Page 4 of 11
http://www.biomedcentral.com/1472-6750/13/40expression of GFP. As expected, a fluorescent reticulated
pattern of the ER network was observed with ER-
targeted GFP (Figure 4A and 4B). In some cases, GFP-
expressing plants displayed small spherical particles ran-
ging between 0.2 – 0.5 μm (Figure 4C and D), similar to
those previously reported in transient expression assays
in N. benthamiana leaves and characterized as PBs [14].
No differences were observed in the fluorescenceFigure 3 Comparison of GFP accumulation in four transgenic
tobacco groups. Each column represents the mean value of 24
independent transgenic plants regenerated for each transformed
construct and error bars indicate the standard error of the mean.
Dotted lines indicate pairwise significant differences at *P < 0.1;
**P < 0.05 using the Wilcoxon-Mann–Whitney test between the
two groups they delineate (e.g. the top dotted line represents a
comparison of I64 GFP and 81V9 GFP-HFBI).
Figure 4 ER pattern and small PBs in leaf tissues of cv. I64
expressing ER-targeted GFP. A-C. Leaf cells from cv. I64 plant 18
with GFP accumulation at 0.35% of TSP. Puzzle-shaped epidermal
cells (ec) are revealed by GFP fluorescence in the ER. The ER also
surrounds the nucleus (n) which appears as circles inside epidermal
cells. B. Close-up of (A) showing the reticulated pattern characteristic
of the ER. C. Small PBs in another cell of cv. I64 plant 18. D. Small
PBs in cv. I64 plant 24 (1.2% TSP).
Figure 6 GFP-HFBI induces the formation of PBs in leaf tissues
of transgenic tobacco 81V9 plants. A. Leaf cells from cultivar 81V9
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particular plant.
GFP-ELP transgenic leaf cells displayed PBs in most
cells (Figure 5A and 5C). These PBs varied in size, ran-
ging in diameter between 0.5 and 2 μm. In these plants,
the simultaneous visualization of PBs and ER was gener-
ally difficult due to the brightness of the PBs. The PBs
were mostly mobile similar to transiently-induced GFP-
ELP PBs in N. benthamiana leaves [14]. In some cases,
the formation of PBs could be seen along the typical ER
network (Figure 5C-D). Also, leaves with different ages
displayed similar patterns of PBs.
GFP-HFBI transgenic plants of both cultivars I64 and
81V9 showed abundant PBs in leaf cells similar to GFP-
ELP transgenic plants (Figure 6A, 6C and 6E). No obvi-
ous differences could be detected in distribution patterns
of PBs in leaves with different ages or between the two
transformed cultivars. Most PBs had a diameter of 0.5 –
1.0 μm (Figure 6B, 6D, 6F), and plants with higher levels
of accumulation also had larger PBs (>1.0 μm) more fre-
quently (compare Figure 6B to 6F). The similarity in PB
appearance and their correlation with accumulation
levels of GFP-HFBI in both tobacco cultivars supports
the idea that the HFBI tag behaves similarly in both
81V9 and I64 (Table 2).
An interesting observation is the presence of PBs in
guard cells of stomata in most plants that formed PBs
regardless of the cultivar and the construct. These cells
had often more PBs than the surrounding epidermal
cells (Figure 7).Figure 5 GFP-ELP induces the formation of PBs in leaves of cv.
I64. A-D. Small PBs form in a T1 progeny of I64 plant 10. C-D.
Formation of PBs can be seen along the ER network. PBs are
heterogeneous in size ranging between 0.5-2 μm.
transgenic plant 11 (0.39% TSP) expressing GFP-HFBI. Formation of
PBs is evident. B. Close-up of picture A showing PBs ranging
between 0.5 - 1.0 μm. C. Leaf cells from cultivar 81V9 transgenic
plant 19 (1.17% TSP) expressing GFP-HFBI; PBs are more abundant.
D. Close-up of picture C showing clusters of PBs. E. Leaf cells from
cultivar I64 transgenic plant 19 (1.68% TSP) expressing GFP-HFBI.
Abundant PBs are present. F. Close-up of E.A threshold value of recombinant protein accumulation is
required for protein body formation in transgenic
tobacco plants
A comparison of the confocal laser scanning microscopy
results and the obtained accumulation levels of different
transgenic lines was performed. This analysis revealed a
relationship between PB formation and recombinant
protein accumulation. Essentially, higher accumulation
levels of GFP were associated with the presence of PBs.
Based on these findings, all transgenic lines were divided
into two different classes according to accumulation
levels and presence or absence of PBs (Table 3). The first
class represents plants with low accumulation levels,
ranging between 0.01% and 0.2% of TSP showing no
PBs. The second class represents plants with accumula-
tion levels of 0.2% of TSP and above. In this class, PBs
form in almost every cell. Moreover, PB frequency and






Protein bodies Protein body size
Absenceb Presence Smallc Larged
I64 GFP-HFBI 0.55% 0 100 97% 3%
I64 GFP-HFBI 1.68% 0 100 37% 63%
81V9 GFP-HFBI 0.77% 0 100 87% 13%
81V9 GFP-HFBI . 1.17% 0 100 48% 52%
a, In total, five leaves per plant were sampled. Two leaf discs per leaf were collected and analyzed by laser scanning confocal microscopy. Ten cells were analyzed
per leaf disc, for a total of 100 cells to avoid any bias.
b, Cells displaying a bright fluorescent ER reticulated pattern.
c, PB diameter <1.0 μm.
d, PB diameter >1.0 μm.
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According to our results, we hypothesize that a thresh-
old of GFP accumulation around 0.2% of TSP is needed
for the formation of PBs in leaves of transgenic tobacco,
regardless of the construct and cultivar used. This hy-
pothesis is supported by the fact that in 93.3% of the an-
alyzed plants this model is fulfilled (Table 3).
Evidence of post-transcriptional gene silencing in low
expressing transgenic plants
Among the stable transgenic lines generated in this
study, some lines yielded low accumulation levels. The
presence of plants with such low accumulation levels is
frequently explained by positional effects of transgene
insertion in the genome [42] or silencing mechanisms of
the plant [43]. The latter is usually attributed to post-
transcriptional gene silencing (PTGS), a ribonucleic acid
(RNA) based silencing mechanism that can be activated
by plant pathogens, transposons and transgenes [44,45].
To evaluate if the low accumulation levels of some of
our transgenic plants was due to an active PTGS mech-
anism, four GFP-HFBI T1 progeny plants of T0 lines
with low accumulation levels were transiently
transformed with an Agrobacterium strain carrying theFigure 7 Guard cells from leaf tissue of a transgenic tobacco
expressing GFP-HFBI contain PBs. PBs in guard cells from cv. 81V9
transgenic plant expressing GFP-HFBI. A. GFP signal from PBs in
guard cells and ER pattern in surrounding epidermal cells. B. Overlay
of the GFP green channel with the transmission light channel
confirming the localization of the PBs to the guard cells.p19 gene from Cymbidium ringspot virus (CymRSV)
[46]. To eliminate any effects due to leaf age and devel-
opmental stage, two leaves (young and old) on each
plant were agro-infiltrated. Starting two days post infil-
tration (2 dpi), a significant increase in GFP accumula-
tion was observed in the p19 infiltrated tissue compared
with the control (Gamborg’s solution). The GFP signal
from the infiltrated tissue was bright enough to be easily
visualized with a UV light. Quantitative analysis of the
p19-infiltrated and control tissue confirmed the positive
effect of p19 on increasing GFP expression levels regard-
less of cultivar type (81V9 vs. I64) or leaf age (young or
old leaves) (Figure 8A-B). These results indicate that low
accumulation levels of a recombinant protein in stable
transgenic plants may be at least partly attributed to
PTGS. PB formation was investigated in p19 infiltrated
leaf tissue at 2 and 5 dpi. No PBs were observed in any
of the infiltrated lines. Given that GFP accumulation
levels for all infiltrated and control tissue were below
0.2% of TSP (Figure 8A), these results are consistent
with the idea that PBs appear at accumulation levels
higher than 0.2% of TSP.
One of the major advantages of transgenic tobacco for
production of recombinant proteins is the high biomass
yield. It has been previously shown that p19 from to-
mato bushy stunt virus (TBSV) induces a hypersensitive
response in tobacco cv. I64 infiltrated tissue which not
only reduces the biomass yield of tobacco plants but also
negatively affects the accumulation levels of co-Table 3 Correlation between GFP accumulation levels and






Less than 0.2% TSP 20 0
More than 0.2% TSP 4 36
a, In total, 60 transgenic lines were analyzed by laser scanning confocal
microscopy to determine presence or absences of PBs. Three leaf samples per
plant were analyzed including one young leaf, one medium-sized leaf and one
old leaf.
Figure 8 Effect of p19 suppressor of gene silencing on
transgenic tobacco lines with low accumulation levels. A.
Quantification of GFP expression in infiltrated tissue of young and old
leaves. Light blue represents the mock-infiltrated area with Gamborg’s
solution (control). Dark blue represents the p19 infiltrated tissue. Error
bars represent technical replicates of GFP quantitation in agro-infiltrated
sectors. Absence of bars indicates no GFP detection B. UV visualization
of p19-infiltrated and mock-infiltrated tissues at 2 dpi in young leaves.
The p19-infiltrated sectors (right) fluoresce green compared to the
mock-infiltrated sectors (left). C. Daylight visualization of p19-infiltrated
and mock-infiltrated young and old leaves at 5 dpi; slight chlorosis is
apparent in young leaves only. Infiltrated areas are delineated with
dotted black lines.
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tored infiltrated 81V9 and I64 leaves from 2 to 5 dpi,
and did not observe any discoloration or other signs of
necrosis before 5 dpi. On day 5 post infiltration, some
slight discoloration was detected mostly in the younger
leaves (Figure 8C). Notably, p19 infiltrated tissue yielded
higher amounts of GFP compared to mock-infiltrated
tissue, contrary to the results obtained with p19 from
TBSV [48].
Discussion
ELP and HFBI fusions improve accumulation levels of GFP
in transgenic tobacco plants
Fusion partners for the expression of recombinant proteins
in plants have been used to solve two major problems: low
accumulation levels and lack of efficient purification
methods for plant made proteins [8]. The ELP and HFBI
fusion tags have been tested in transient expression experi-
ments and shown to increase recombinant protein accu-
mulation levels [13,14,30]. ELP was also shown to increase
the accumulation of recombinant proteins in stable trans-
genic plants [49,50], while HFBI has not been tested in a
stable plant system and neither were investigated for the
appearance of PBs in stable transgenic plants.
Analysis of the various transgenic tobacco plants pro-
duced in this study demonstrated that ELP and HFBI tags
can be efficiently used in transgenic plants. Compared with
unfused GFP, the use of both tags at least doubled the
amount of GFP (Figure 3). To our knowledge, this is the
first report showing that the HFBI tag is functional in
transgenic plants, where it positively impacts the accumu-
lation of the protein of interest. Additionally, no differences
were found between cultivars I64 and 81V9 transformed
with GFP-HFBI (Figure 3). This finding opens the possibil-
ity of using cultivars with different properties that can be
beneficial for the expression of a particular protein. Culti-
var I64 produces high biomass and normal alkaloid levels,
while 81V9 cultivar is a low alkaloid cultivar with slightly
lower biomass [9], a property that can be exploited for oral
administration of therapeutic biologicals such as vaccines
for humans and animals. Expensive purification processes
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achieved [51,52].
This is also the first study to directly compare ELP
and HFBI tags. We found that ELP increased the accu-
mulation levels of GFP (Figure 2) to a lesser extent than
HFBI. This result is consistent with published transient
expression data of the same constructs [14,30]. However,
a similar comparison with other recombinant proteins
should be conducted before definitive conclusions can
be drawn since the conformation of individual proteins
could be affected by the fusion tags, especially proteins
that require complex folding and assembly.
PB formation is induced by high accumulation of
recombinant proteins
The ER is the first gateway of the protein secretory path-
way. In cereal seeds, the endomembrane system is able
to generate multiple ER-derived compartments or PBs,
primarily used to store reserve compounds, such as stor-
age proteins, lipids, carbohydrates and minerals. As
such, protein bodies provide a suitable environment for
folding, assembling, and long-term storage of massive
amounts of proteins [53,54]. In this study, we show that
PBs form in leaves of transgenic plants expressing ER-
targeted GFP, GFP-ELP and GFP-HFBI at levels higher
than 0.2% of TSP. To our knowledge, this is the first re-
port that demonstrates that there is a threshold value
needed for the formation of PBs in tobacco leaves, and
that PBs are not exclusively induced by the presence of
the fusion tags. Indeed, despite an overall lower accumu-
lation of unfused GFP, PBs were found in four of the six
transgenic plants that accumulated more than 0.2% of
TSP and were examined by confocal microscopy. This
finding suggests that the ELP and HFBI tags are not es-
sential for the formation of PBs, although they help to
increase the accumulation levels and therefore enhance
PBs formation.
Evidence of post-transcriptional gene silencing in plants
with low levels of GFP accumulation
Plant pathogenic viruses have evolved strong PTGS sup-
pressors that can act at different levels of the silencing
pathway. One of the best characterized suppressors,
expressed by members of the Tombusvirus family, is the
p19 protein. The p19 suppressor has been successfully
used in transient expression assays for increasing the
yield of several recombinant proteins [55-58]. The ob-
served variation in accumulation levels of recombinant
proteins in different stable transgenic plants can be in-
duced by the activation of plant PTGS mechanism, a si-
lencing system that can be activated by transgenes if
their expression levels are high [55,59,60].
Results from agro-infiltration of CymRSV p19 in four
of the low expressing GFP-HFBI tobacco plants suggestthat some of these plants may have been silenced. This
was shown by the observed increase in accumulation of
the recombinant protein after infiltration with p19.
CymRSV p19 infiltration of tobacco cultivars I64 and
81V9 did not cause necrosis in the infiltrated areas, dif-
fering from a recent report where p19 from TBSV-
induced necrosis in several tobacco cultivars including
cv. I64 starting at 3 dpi [48]. Other than different origins
of the p19 proteins used in these two studies, the age
at which tobacco plants were infected with the p19
varied. In our case, the infiltrated tobacco cultivars were
12–14 weeks old while Garabagi et al. [48] used 6–8
week-old plants. In their experiment Garabagi et al. [48]
observed complete necrosis by 5 dpi in cv. I64, while
we observed slight yellowing of infiltrated leaf sectors
in young leaves only and no effect on older leaves of 12–
14 week-old plants. The difference in results could be
due to different p19 genes which are identical at 68% of
amino acid positions [47] but also to the age of the plant
as well as the developmental stage of the leaves.
Conclusions
In this study, we have shown that ELP and HFBI fusion tags
expressed in two different cultivars of transgenic tobacco,
help to increase the accumulation level of recombinant
GFP, and induce formation of PBs. We have also shown
that a threshold concentration (0.2% of TSP) of GFP was
required for PBs to form, regardless of the fusion partner’s
presence or absence. Additionally, we have shown that
PTGS can play a role in expression and accumulation of re-
combinant proteins in transgenic plants.
Methods
Generation of tobacco stable transgenic plants
Previously published constructs were used for tobacco
stable transformation [14,30] (Figure 1). Tobacco cultivars
I64 and 81V9 were transformed using Agrobacterium
according to Horsch et al. [61]. Tobacco plants were
grown in a greenhouse at 24°C, 16 hour light and 22°C,
8 hour dark for 12–14 weeks. Plants were fertilized
with the classic water soluble fertilizer (N : P : K = 20 : 20 :
20) weekly at 4 g/L (Plant Products, Brampton, ON,
Canada).
Transient expression in tobacco stable transgenic plants
Leaves of tobacco cultivars 81V9 and I64 expressing
GFP-HFBI were agro-infiltrated [62] using a needle-less
syringe with an Agrobacterium strain containing p19
from CymRSV [46]. Briefly, the A. tumefaciens culture
was grown to an optical density at 600 nm (OD600) of 0.5-
0.8. The culture was centrifuged at 1000 g for 30 minutes
and the pellet was resuspended in agro-infiltration
solution (3.2 g/L Gamborg’s B5 plus vitamins, 20 g/L
sucrose, 10 mM MES pH 5.6, 200 μM 4′-Hydroxy-
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0.3 and then incubated at room temperature with
gentle agitation for 1 hour. A young leaf (the third
leaf from the top of the plant), a medium-sized leaf
and an old leaf (the 8th leaf from the top) from dif-
ferent stable transgenic plants were infiltrated with
the bacterial suspension. Leaf tissue samples were
collected 5 days post infiltration.
Tissue sample collection and protein extraction
Leaf tissue samples were collected from each stable trans-
genic plant when the plant had 8 fully expanded leaves. In
total, 8 leaf discs, 5 mm in diameter, were collected per
plant, each from a different leaf and froze instantly in li-
quid nitrogen. Frozen leaf discs were homogenized using
a Tissue Lyser (Qiagen), extracted in 600 μl of plant pro-
tein extraction buffer containing phosphate-buffered sa-
line (PBS: 8 g/L NaCl, 1.16 g/L Na2HPO4, 0.2 g/L
KH2PO4, 0.2 g/L KCl, pH 7.4), 1 mM EDTA, 1 mM
phenylmethanesulfonylfluoride (PMSF), 1 μg/ml leupeptin
0.1% Tween-20, 100 mM sodium L-ascorbate, and
centrifuged twice at 14,000 g for 5 minutes at 4°C. The
extracted proteins in the supernatant were kept on ice,
TSP was determined by a Bradford assay using bovine
serum albumin (BSA) as a standard (Bio-Rad) [63].
Quantification of GFP levels
GFP quantification of the recombinant proteins was
performed either using the immunodot blot technique
or fluorometer. For immunodot blot quantitation, serial
dilutions of each sample were prepared and three tech-
nical replicates of each dilution were spotted onto a
nitrocellulose membrane (Bio-Rad). A dilution series of
GFP-HFBI, purified by ATPS, was used as a standard on
every blot to quantify the amount of GFP. Membranes
were blocked overnight at 4°C in blocking solution
containing tris-buffered saline (TBS-T 24.2 g/L Tris
base, 175.3 g/L NaCl, pH 7.5, 0.1% Tween-20) and 3%
(w/v) powdered skim milk. Membranes were incubated
for 1 hour at room temperature with mouse monoclonal
anti GFP primary antibody (Clontech, Living Colors® A.
v. monoclonal antibody (JL-8), Cat. No. 632381) diluted
1:5000 in blocking solution. Membranes were washed
three times for 15 minutes with TBS-T and incubated
for an hour at room temperature with a horseradish per-
oxidase (HRP)-conjugated goat-anti mouse IgG secon-
dary antibody (Bio-Rad, Cat. No. 170–6515) diluted in
1:3000 in blocking solution. Membranes were visualized
using the enhanced chemiluminescence (ECL) detection
system (GE Healthcare, Mississauga, ON, Canada)
according to the manufacturers protocol, and scanned
using a ChemidocXRS (Bio-Rad). Scanned membranes
were analyzed using TotalLab TL 100 software (Nonlinear
Dynamics, Durham, USA). All sample dilutions werecompared to a GFP-HFBI standard that was produced in
the lab. For this purpose, Agrobacterium-mediated transi-
ent expression was used to produce GFP-HFBI recombin-
ant protein in N. benthamiana plants. The recombinant
protein was purified from infiltrated leaf tissue using
ATPS according to Joensuu et al. [30] and quantified using
SDS-PAGE. GFP-HFBI at 4, 8, 12, 16, 20 and 24 ng/μl
were prepared and used to create a standard curve for ex-
trapolating concentrations of GFP in transgenic plants.
GFP was quantified by fluorometry in leaf extracts by
measuring fluorescent intensity with a Synergy™ 2
microplate reader (BioTek, VT, USA). Briefly, 200 μl of
serially diluted samples in PBS were added to 96 well black
opaque flat bottom polystyrene TC-treated microplates
(Corning, MA, USA). Fluorescence was detected using ex-
citation and emission at 485 and 516 nm, respectively. To
account for background fluorescence of the plant tissue,
extract from mock-infiltrated tissue with Gamborg’s solu-
tion was used to normalize the data. All sample dilutions
were compared to a GFP-HFBI standard. Several concen-
trations of purified GFP were used (ranging between 125
to 2000 ng/ml) to draw the standard curve. The mean of
three technical replicates of each standard point and di-
luted sample was used as the credible value.
Statistical analysis
Minitab 15 statistical package (Minitab Ltd., Coventry,
UK) was used to perform the statistical analysis.
Kolmogorov-Smirnov normality test (Lilliefor’s test) was
first applied to the quantification data gathered from the
24 independent transformants that were regenerated per
transformed construct (96 in total). The Kruskal-Wallis
non-parametric test was used to assess if there were stat-
istical differences between the median values of the four
different transgenic groups. Post-hoc comparisons be-
tween groups of transgenic lines were performed using
the Wilcoxon-Mann–Whitney test.
Tissue sampling of stable transgenic plants and confocal
microscopy analysis
Tissue samples were collected from fully expanded and de-
veloped leaves. In total, 3 leaf discs, 4 mm in diameter,
were collected per plant, each from a different size leaf
(one from a young leaf (third leaf from the top of the
plant), one from a medium-size leaf (5th leaf from the top)
and one from an old leaf (8th leaf from the top)). Samples
were immediately imaged with a Leica TCS SP2 confocal
laser scanning inverted microscope (Leica Microsystems,
Wetzlar, Germany) equipped with a 63X water immersion
objective. To visualize GFP fluorescence, excitation with a
488 nm argon laser was used and the emission was
detected at 500–530 nm. Collected images were analyzed
using the Leica Application Suite for Advanced Fluores-
cence (LAS AF, V2.3.5) (Leica Microsystem, Germany).
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